<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Defective liver gluconeogenesis is the main mechanism leading to fasting <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and, in concert with <z:hpo ids='HP_0001397'>steatosis</z:hpo>, it is the hallmark of hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Experimental <z:hpo ids='HP_0001513'>obesity</z:hpo> results, at least in part, from hypothalamic <z:mp ids='MP_0001845'>inflammation</z:mp>, which leads to leptin resistance and defective regulation of energy homeostasis </plain></SENT>
<SENT sid="2" pm="."><plain>Pharmacological or genetic disruption of hypothalamic <z:mp ids='MP_0001845'>inflammation</z:mp> restores leptin sensitivity and reduces <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we evaluate the effect of a hypothalamic anti-inflammatory approach to regulating hepatic responsiveness to insulin </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0001261'>Obese</z:mp> rodents were treated by intracerebroventricular injections, with immunoneutralizing antibodies against Toll-like receptor (TLR)4 or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)α, and insulin signal transduction, <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo>, and gluconeogenesis were evaluated </plain></SENT>
<SENT sid="5" pm="."><plain>The inhibition of either TLR4 or TNFα reduced hypothalamic <z:mp ids='MP_0001845'>inflammation</z:mp>, which was accompanied by the reduction of hypothalamic resistance to leptin and improved insulin signal transduction in the liver </plain></SENT>
<SENT sid="6" pm="."><plain>This was accompanied by reduced <z:hpo ids='HP_0001397'>liver steatosis</z:hpo> and reduced hepatic expression of markers of <z:hpo ids='HP_0001397'>steatosis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, the inhibition of hypothalamic <z:mp ids='MP_0001845'>inflammation</z:mp> restored defective liver <z:chebi fb="105" ids="17234">glucose</z:chebi> production </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these beneficial effects were abrogated by vagotomy </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, the inhibition of hypothalamic <z:mp ids='MP_0001845'>inflammation</z:mp> in <z:hpo ids='HP_0001513'>obesity</z:hpo> results in improved hepatic insulin signal transduction, leading to reduced <z:hpo ids='HP_0001397'>steatosis</z:hpo> and reduced gluconeogenesis </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these effects are mediated by parasympathetic signals delivered by the vagus nerve </plain></SENT>
</text></document>